Why WVE? Wave Life Sciences Ltd. Analysis, Price & AI Insights | Whystock
WVE
$7.32+0.26 (+3.68%)
Market ClosedLast close May 1
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.